Senior executives and larger owner exercise, pro rata, warrants of series TO 6 B for approximately SEK 0.7 million.
Lund, Sweden - Clinical Laserthermia Systems AB ("CLS" or the "Company") announces that senior executives and a larger owner exercise, pro rata, warrants of series TO 6 B for approximately SEK 0.7 million. The exercise period for the warrants of TO 6 B began on January 23, 2024 and continues until February 6, 2024. The last day of trading in warrants of series TO 6 B is February 2, 2024.Senior executives and a larger owner in CLS (directly or through companies), as described below, exercise, pro rata, warrants of series TO 6 B for a total of approximately SEK 0.7 million: · Hans